Logo

American Heart Association

  110
  0


Final ID:

Debate: Mitral Valve Surgery in the Era of TAVR: When and Why It Remains the Preferred Approach

  • Emerson, Dominic  ( CSHS , Los Angeles , California , United States )
  • Gillinov, A Marc  ( Cleveland Clinic , Cleveland , Ohio , United States )
  • Adams, David  ( MOUNT SINAI MEDICAL CENTER , New York , New York , United States )
  • Atluri, Pavan  ( UNIVERSITY OF PENNSYLVANIA , Philadelphia , Pennsylvania , United States )
  • Arnaoutakis, George  ( UT Health – Austin , Austin , Texas , United States )
  • Author Disclosures:
    Dominic Emerson: DO have relevant financial relationships ; Consultant:Intuitive Surgical:Active (exists now) ; Consultant:Edwards:Active (exists now) | A MARC GILLINOV: No Answer | David Adams: DO have relevant financial relationships ; Other (please indicate in the box next to the company name):Edwards Lifesciences, Medtronic:Active (exists now) | Pavan Atluri: DO NOT have relevant financial relationships | George Arnaoutakis: DO have relevant financial relationships ; Consultant:Artivion:Active (exists now) ; Consultant:Abbott:Active (exists now) ; Consultant:Terumo Aortic:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

More abstracts on this topic:
TAVR Explant and AVR

Kaneko Tsuyoshi, Fukuhara Shinichi, Bapat Vinayak, Arnaoutakis George

Surgical Options Should Be Based on progression Rate and Type of TAVR Implanted

Fukuhara Shinichi, Yang Bo, Chen Edward, Sultan Ibrahim

More abstracts from these authors:
Panel

Arnaoutakis George, Chen Edward

Mitral Valve Surgery in Arrhythmogenic Mitral Regurgitation: Special Considerations

Borger Michael, Adams David, Gillinov A Marc, Nguyen Tom, Ramzy Danny

You have to be authorized to contact abstract author. Please, Login
Not Available